Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Resolved | 2017-03-11 | 2019-03-21 | 564 |
AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-02 | 75166 |
AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-05-08 | 2019-05-10 | 83440 |
AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-07-16 | 2020-01-24 | 89482 |
AVALIDE | 12.5MG 300MG | TABLET | Avoided shortage | 2022-04-14 | 2022-08-11 | 158890 |
AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2022-08-11 | 2022-08-11 | 166530 |
IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2018-11-12 | 2018-12-29 | 66698 |
IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2019-04-22 | 2019-06-22 | 82135 |
SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2019-03-05 | 2020-07-20 | 77655 |
SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2019-04-01 | 2020-06-22 | 80194 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 |